Dr. David I Pincus, D.M.H Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12429 Cedar Rd, Ste 2, Cleveland Hts, OH 44106 Phone: 216-791-1414 Fax: 216-791-1414 |
Dr. Judith I Shields, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2469 Fairmount Blvd, Ste. 320, Cleveland Hts, OH 44106 Phone: 216-262-6206 |
Yael Y Greenberg, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 12429 Cedar Rd, Suite 18, Cleveland Hts, OH 44106 Phone: 216-921-1779 |
Shannon Nicole Johanson, ED. S. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 3970 Mayfield Rd, Cleveland Hts, OH 44121 Phone: 216-242-6324 |
Dr. Debra Lynn Reble, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2702 Scarborough Rd, Cleveland Hts, OH 44106 Phone: 216-320-0160 |
Olga Vaynberg Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 2405 Roxboro Rd, Cleveland Hts, OH 44106 Phone: 216-371-7115 |
Maureen Elizabeth Kreick, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2460 Fairmount Blvd, Suite 323, Cleveland Hts, OH 44106 Phone: 216-229-4290 |
Dr. Debra El-amin, PSY.D. Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 2460 Fairmount Blvd, 320, Cleveland Hts, OH 44106 Phone: 216-337-7649 |
Dr. David Arthur Krauss, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3260 Euclid Heights Blvd, Cleveland Hts, OH 44118 Phone: 216-371-8766 |
News Archive
Seasonal influenza vaccines are typically less than 50 percent effective, according to Centers for Disease Control and Prevention studies. Research at the University of Alabama at Birmingham, published this week in Nature Immunology, may point a path to more effective vaccines.
A U.S. federal court has sanctioned Chevron and its lawyers at Gibson Dunn & Crutcher for abusive questioning during a deposition related to the oil giant's multi-billion dollar liability in Ecuador for environmental contamination, according to court papers made available today.
Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain, today announced that it has officially begun to merge its operations with Talecris Biotherapeutics in order to function as one company, following its acquisition of Talecris on June 1.
Synergetics USA, Inc., announced today the signing of a pair of agreements with Alcon Laboratories, Inc. granting Alcon a license to sell certain products manufactured by Synergetics for worldwide distribution on a co-exclusive basis throughout the extensive Alcon network and covering the terms of supply of such products to Alcon by Synergetics.
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it dosed the first infant in the 12 mg dose group in the Phase 2 study evaluating ISIS-SMNRx in infants with Type I spinal muscular atrophy (SMA).
› Verified 9 days ago